Bonaventura Clotet

Bonaventura Clotet,Specialized in Internal Medicine and Infectious Diseases. PhD in Medical Sciences in 1981. He is Head of the Infectious Diseases department and Director of the Retrovirology Laboratory “irsiCaixa” Foundation at the Hospital Universitari Germans Trias i Pujol since 1993.  He is also President of the Foundation “Lluita contra la SIDA”, founded in 1992. Since 2006, he is co-director of the HIVACAT project for the development of the AIDS vaccine in Catalonia, Spain. Director of the Master in AIDS Pathogenesis and Treatment (Universitat Autònoma de Barcelona) since 2011. Dr. Clotet is member of the steering committee of EuroSIDA Scientific Advisory Board Member. He is the director of the Chair of AIDS and Related Diseases at the University of Vic (UVic), created in October 2013. In October 2012, he was awarded by the Catalan Government (Generalitat de Catalunya) with the Josep Trueta medal to Sanitary Merit for his contributions to the research in the HIV field. In April 2016, Clotet has been awarded with the 'Creu de St. Jordi' for being one of the most internationally renowned HIV researchers. Dr. Clotet has created 2 spin-offs from IrsiCaixa:AELIX Therapeutics (December 2015) for the development of a therapeutic vaccine for HIV infected patients and  AlbaJuna Therapeutics (January 2016) for the development of an Immunoglobulin for curing & preventing HIV. More than 700 papers in international journals (Impact factor: >5.000 // H-index: 81)